Global Heart Failure Treatment Market Growth (Status and Outlook) 2025-2031

September 2025 | 136 pages | ID: G31598CE0FCFEN
LP Information

Abstracts

According to this study, the global Heart Failure Treatment market size will reach US$ million by 2031.

The main treatment for heart failure is etiological treatment.Because heart failure is the ultimate state of the heart, the causes of heart failure are different.Some people may have hyperthyroidism induced heart failure, and the treatment plan is to actively correct hyperthyroidism.Some people because arrhythmia causes tachycardia, cardiomyopathy, control arrhythmia, heart failure will improve naturally.There are still some people who have heart failure caused by ischemic heart disease. They need coronary angiography to actively change the state of heart ischemia, and heart failure can be recovered to a certain extent.There are other diseases, so the etiology of heart failure is important.If heart failure occurs, take active medication.Above all, want to use the therapeutics of heart failure normatively, strong heart, diuresis, dilate blood-vessel is a few treatment means to heart failure acute period, can alleviate improve the symptom of the patient.Chronic treatment of heart failure requires the long-term use of ACEI or ARB, beta blockers and diuretic drugs to reduce the length of hospital stay in patients with heart failure and improve their quality of life, as well as three-chamber pacemaker implantation and heart transplantation.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Heart Failure Treatment Industry Forecast” looks at past sales and reviews total world Heart Failure Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Heart Failure Treatment sales for 2025 through 2031. With Heart Failure Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Heart Failure Treatment industry.

This Insight Report provides a comprehensive analysis of the global Heart Failure Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Heart Failure Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Heart Failure Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Heart Failure Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Heart Failure Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Heart Failure Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Drug Treatment
• Surgical Treatment

Segmentation by Application:

• Acute Heart Failure
• Chronic Heart Failure

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Novartis
• Merck
• Sanofi
• Johnson & Johnson
• AstraZeneca
• GlaxoSmithKline
• Amgen
• Bayer
• BMS
• Cardiorentis
• Cytokinetics
• Ono Pharmaceuticals
• Mylan
• NCPC
• Xinhua Group
• Xudong Haipu Pharmaceutical

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Heart Failure Treatment Market Size (2020-2031)
  2.1.2 Heart Failure Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Heart Failure Treatment by Country/Region (2020, 2024 & 2031)
2.2 Heart Failure Treatment Segment by Type
  2.2.1 Drug Treatment
  2.2.2 Surgical Treatment
2.3 Heart Failure Treatment Market Size by Type
  2.3.1 Heart Failure Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Heart Failure Treatment Market Size Market Share by Type (2020-2025)
2.4 Heart Failure Treatment Segment by Application
  2.4.1 Acute Heart Failure
  2.4.2 Chronic Heart Failure
2.5 Heart Failure Treatment Market Size by Application
  2.5.1 Heart Failure Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Heart Failure Treatment Market Size Market Share by Application (2020-2025)

3 HEART FAILURE TREATMENT MARKET SIZE BY PLAYER

3.1 Heart Failure Treatment Market Size Market Share by Player
  3.1.1 Global Heart Failure Treatment Revenue by Player (2020-2025)
  3.1.2 Global Heart Failure Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Heart Failure Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HEART FAILURE TREATMENT BY REGION

4.1 Heart Failure Treatment Market Size by Region (2020-2025)
4.2 Global Heart Failure Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Heart Failure Treatment Market Size Growth (2020-2025)
4.4 APAC Heart Failure Treatment Market Size Growth (2020-2025)
4.5 Europe Heart Failure Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Heart Failure Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Heart Failure Treatment Market Size by Country (2020-2025)
5.2 Americas Heart Failure Treatment Market Size by Type (2020-2025)
5.3 Americas Heart Failure Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Heart Failure Treatment Market Size by Region (2020-2025)
6.2 APAC Heart Failure Treatment Market Size by Type (2020-2025)
6.3 APAC Heart Failure Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Heart Failure Treatment Market Size by Country (2020-2025)
7.2 Europe Heart Failure Treatment Market Size by Type (2020-2025)
7.3 Europe Heart Failure Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Heart Failure Treatment by Region (2020-2025)
8.2 Middle East & Africa Heart Failure Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Heart Failure Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HEART FAILURE TREATMENT MARKET FORECAST

10.1 Global Heart Failure Treatment Forecast by Region (2026-2031)
  10.1.1 Global Heart Failure Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Heart Failure Treatment Forecast
  10.1.3 APAC Heart Failure Treatment Forecast
  10.1.4 Europe Heart Failure Treatment Forecast
  10.1.5 Middle East & Africa Heart Failure Treatment Forecast
10.2 Americas Heart Failure Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Heart Failure Treatment Forecast
  10.2.2 Canada Market Heart Failure Treatment Forecast
  10.2.3 Mexico Market Heart Failure Treatment Forecast
  10.2.4 Brazil Market Heart Failure Treatment Forecast
10.3 APAC Heart Failure Treatment Forecast by Region (2026-2031)
  10.3.1 China Heart Failure Treatment Market Forecast
  10.3.2 Japan Market Heart Failure Treatment Forecast
  10.3.3 Korea Market Heart Failure Treatment Forecast
  10.3.4 Southeast Asia Market Heart Failure Treatment Forecast
  10.3.5 India Market Heart Failure Treatment Forecast
  10.3.6 Australia Market Heart Failure Treatment Forecast
10.4 Europe Heart Failure Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Heart Failure Treatment Forecast
  10.4.2 France Market Heart Failure Treatment Forecast
  10.4.3 UK Market Heart Failure Treatment Forecast
  10.4.4 Italy Market Heart Failure Treatment Forecast
  10.4.5 Russia Market Heart Failure Treatment Forecast
10.5 Middle East & Africa Heart Failure Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Heart Failure Treatment Forecast
  10.5.2 South Africa Market Heart Failure Treatment Forecast
  10.5.3 Israel Market Heart Failure Treatment Forecast
  10.5.4 Turkey Market Heart Failure Treatment Forecast
10.6 Global Heart Failure Treatment Forecast by Type (2026-2031)
10.7 Global Heart Failure Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Heart Failure Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Heart Failure Treatment Product Offered
  11.1.3 Pfizer Heart Failure Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Novartis
  11.2.1 Novartis Company Information
  11.2.2 Novartis Heart Failure Treatment Product Offered
  11.2.3 Novartis Heart Failure Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Novartis Main Business Overview
  11.2.5 Novartis Latest Developments
11.3 Merck
  11.3.1 Merck Company Information
  11.3.2 Merck Heart Failure Treatment Product Offered
  11.3.3 Merck Heart Failure Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Merck Main Business Overview
  11.3.5 Merck Latest Developments
11.4 Sanofi
  11.4.1 Sanofi Company Information
  11.4.2 Sanofi Heart Failure Treatment Product Offered
  11.4.3 Sanofi Heart Failure Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Sanofi Main Business Overview
  11.4.5 Sanofi Latest Developments
11.5 Johnson & Johnson
  11.5.1 Johnson & Johnson Company Information
  11.5.2 Johnson & Johnson Heart Failure Treatment Product Offered
  11.5.3 Johnson & Johnson Heart Failure Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Johnson & Johnson Main Business Overview
  11.5.5 Johnson & Johnson Latest Developments
11.6 AstraZeneca
  11.6.1 AstraZeneca Company Information
  11.6.2 AstraZeneca Heart Failure Treatment Product Offered
  11.6.3 AstraZeneca Heart Failure Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 AstraZeneca Main Business Overview
  11.6.5 AstraZeneca Latest Developments
11.7 GlaxoSmithKline
  11.7.1 GlaxoSmithKline Company Information
  11.7.2 GlaxoSmithKline Heart Failure Treatment Product Offered
  11.7.3 GlaxoSmithKline Heart Failure Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 GlaxoSmithKline Main Business Overview
  11.7.5 GlaxoSmithKline Latest Developments
11.8 Amgen
  11.8.1 Amgen Company Information
  11.8.2 Amgen Heart Failure Treatment Product Offered
  11.8.3 Amgen Heart Failure Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Amgen Main Business Overview
  11.8.5 Amgen Latest Developments
11.9 Bayer
  11.9.1 Bayer Company Information
  11.9.2 Bayer Heart Failure Treatment Product Offered
  11.9.3 Bayer Heart Failure Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Bayer Main Business Overview
  11.9.5 Bayer Latest Developments
11.10 BMS
  11.10.1 BMS Company Information
  11.10.2 BMS Heart Failure Treatment Product Offered
  11.10.3 BMS Heart Failure Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 BMS Main Business Overview
  11.10.5 BMS Latest Developments
11.11 Cardiorentis
  11.11.1 Cardiorentis Company Information
  11.11.2 Cardiorentis Heart Failure Treatment Product Offered
  11.11.3 Cardiorentis Heart Failure Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Cardiorentis Main Business Overview
  11.11.5 Cardiorentis Latest Developments
11.12 Cytokinetics
  11.12.1 Cytokinetics Company Information
  11.12.2 Cytokinetics Heart Failure Treatment Product Offered
  11.12.3 Cytokinetics Heart Failure Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Cytokinetics Main Business Overview
  11.12.5 Cytokinetics Latest Developments
11.13 Ono Pharmaceuticals
  11.13.1 Ono Pharmaceuticals Company Information
  11.13.2 Ono Pharmaceuticals Heart Failure Treatment Product Offered
  11.13.3 Ono Pharmaceuticals Heart Failure Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Ono Pharmaceuticals Main Business Overview
  11.13.5 Ono Pharmaceuticals Latest Developments
11.14 Mylan
  11.14.1 Mylan Company Information
  11.14.2 Mylan Heart Failure Treatment Product Offered
  11.14.3 Mylan Heart Failure Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Mylan Main Business Overview
  11.14.5 Mylan Latest Developments
11.15 NCPC
  11.15.1 NCPC Company Information
  11.15.2 NCPC Heart Failure Treatment Product Offered
  11.15.3 NCPC Heart Failure Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 NCPC Main Business Overview
  11.15.5 NCPC Latest Developments
11.16 Xinhua Group
  11.16.1 Xinhua Group Company Information
  11.16.2 Xinhua Group Heart Failure Treatment Product Offered
  11.16.3 Xinhua Group Heart Failure Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.16.4 Xinhua Group Main Business Overview
  11.16.5 Xinhua Group Latest Developments
11.17 Xudong Haipu Pharmaceutical
  11.17.1 Xudong Haipu Pharmaceutical Company Information
  11.17.2 Xudong Haipu Pharmaceutical Heart Failure Treatment Product Offered
  11.17.3 Xudong Haipu Pharmaceutical Heart Failure Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.17.4 Xudong Haipu Pharmaceutical Main Business Overview
  11.17.5 Xudong Haipu Pharmaceutical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Heart Failure Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Heart Failure Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Drug Treatment
Table 4. Major Players of Surgical Treatment
Table 5. Heart Failure Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Heart Failure Treatment Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Heart Failure Treatment Market Size Market Share by Type (2020-2025)
Table 8. Heart Failure Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Heart Failure Treatment Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Heart Failure Treatment Market Size Market Share by Application (2020-2025)
Table 11. Global Heart Failure Treatment Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Heart Failure Treatment Revenue Market Share by Player (2020-2025)
Table 13. Heart Failure Treatment Key Players Head office and Products Offered
Table 14. Heart Failure Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Heart Failure Treatment Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Heart Failure Treatment Market Size Market Share by Region (2020-2025)
Table 19. Global Heart Failure Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Heart Failure Treatment Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Heart Failure Treatment Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Heart Failure Treatment Market Size Market Share by Country (2020-2025)
Table 23. Americas Heart Failure Treatment Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Heart Failure Treatment Market Size Market Share by Type (2020-2025)
Table 25. Americas Heart Failure Treatment Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Heart Failure Treatment Market Size Market Share by Application (2020-2025)
Table 27. APAC Heart Failure Treatment Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Heart Failure Treatment Market Size Market Share by Region (2020-2025)
Table 29. APAC Heart Failure Treatment Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Heart Failure Treatment Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Heart Failure Treatment Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Heart Failure Treatment Market Size Market Share by Country (2020-2025)
Table 33. Europe Heart Failure Treatment Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Heart Failure Treatment Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Heart Failure Treatment Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Heart Failure Treatment Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Heart Failure Treatment Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Heart Failure Treatment
Table 39. Key Market Challenges & Risks of Heart Failure Treatment
Table 40. Key Industry Trends of Heart Failure Treatment
Table 41. Global Heart Failure Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Heart Failure Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Heart Failure Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Heart Failure Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Pfizer Details, Company Type, Heart Failure Treatment Area Served and Its Competitors
Table 46. Pfizer Heart Failure Treatment Product Offered
Table 47. Pfizer Heart Failure Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Pfizer Main Business
Table 49. Pfizer Latest Developments
Table 50. Novartis Details, Company Type, Heart Failure Treatment Area Served and Its Competitors
Table 51. Novartis Heart Failure Treatment Product Offered
Table 52. Novartis Heart Failure Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Novartis Main Business
Table 54. Novartis Latest Developments
Table 55. Merck Details, Company Type, Heart Failure Treatment Area Served and Its Competitors
Table 56. Merck Heart Failure Treatment Product Offered
Table 57. Merck Heart Failure Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Merck Main Business
Table 59. Merck Latest Developments
Table 60. Sanofi Details, Company Type, Heart Failure Treatment Area Served and Its Competitors
Table 61. Sanofi Heart Failure Treatment Product Offered
Table 62. Sanofi Heart Failure Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Sanofi Main Business
Table 64. Sanofi Latest Developments
Table 65. Johnson & Johnson Details, Company Type, Heart Failure Treatment Area Served and Its Competitors
Table 66. Johnson & Johnson Heart Failure Treatment Product Offered
Table 67. Johnson & Johnson Heart Failure Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Latest Developments
Table 70. AstraZeneca Details, Company Type, Heart Failure Treatment Area Served and Its Competitors
Table 71. AstraZeneca Heart Failure Treatment Product Offered
Table 72. AstraZeneca Heart Failure Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. AstraZeneca Main Business
Table 74. AstraZeneca Latest Developments
Table 75. GlaxoSmithKline Details, Company Type, Heart Failure Treatment Area Served and Its Competitors
Table 76. GlaxoSmithKline Heart Failure Treatment Product Offered
Table 77. GlaxoSmithKline Heart Failure Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. GlaxoSmithKline Main Business
Table 79. GlaxoSmithKline Latest Developments
Table 80. Amgen Details, Company Type, Heart Failure Treatment Area Served and Its Competitors
Table 81. Amgen Heart Failure Treatment Product Offered
Table 82. Amgen Heart Failure Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Amgen Main Business
Table 84. Amgen Latest Developments
Table 85. Bayer Details, Company Type, Heart Failure Treatment Area Served and Its Competitors
Table 86. Bayer Heart Failure Treatment Product Offered
Table 87. Bayer Heart Failure Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Bayer Main Business
Table 89. Bayer Latest Developments
Table 90. BMS Details, Company Type, Heart Failure Treatment Area Served and Its Competitors
Table 91. BMS Heart Failure Treatment Product Offered
Table 92. BMS Heart Failure Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. BMS Main Business
Table 94. BMS Latest Developments
Table 95. Cardiorentis Details, Company Type, Heart Failure Treatment Area Served and Its Competitors
Table 96. Cardiorentis Heart Failure Treatment Product Offered
Table 97. Cardiorentis Heart Failure Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Cardiorentis Main Business
Table 99. Cardiorentis Latest Developments
Table 100. Cytokinetics Details, Company Type, Heart Failure Treatment Area Served and Its Competitors
Table 101. Cytokinetics Heart Failure Treatment Product Offered
Table 102. Cytokinetics Heart Failure Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Cytokinetics Main Business
Table 104. Cytokinetics Latest Developments
Table 105. Ono Pharmaceuticals Details, Company Type, Heart Failure Treatment Area Served and Its Competitors
Table 106. Ono Pharmaceuticals Heart Failure Treatment Product Offered
Table 107. Ono Pharmaceuticals Heart Failure Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Ono Pharmaceuticals Main Business
Table 109. Ono Pharmaceuticals Latest Developments
Table 110. Mylan Details, Company Type, Heart Failure Treatment Area Served and Its Competitors
Table 111. Mylan Heart Failure Treatment Product Offered
Table 112. Mylan Heart Failure Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Mylan Main Business
Table 114. Mylan Latest Developments
Table 115. NCPC Details, Company Type, Heart Failure Treatment Area Served and Its Competitors
Table 116. NCPC Heart Failure Treatment Product Offered
Table 117. NCPC Heart Failure Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. NCPC Main Business
Table 119. NCPC Latest Developments
Table 120. Xinhua Group Details, Company Type, Heart Failure Treatment Area Served and Its Competitors
Table 121. Xinhua Group Heart Failure Treatment Product Offered
Table 122. Xinhua Group Heart Failure Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Xinhua Group Main Business
Table 124. Xinhua Group Latest Developments
Table 125. Xudong Haipu Pharmaceutical Details, Company Type, Heart Failure Treatment Area Served and Its Competitors
Table 126. Xudong Haipu Pharmaceutical Heart Failure Treatment Product Offered
Table 127. Xudong Haipu Pharmaceutical Heart Failure Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Xudong Haipu Pharmaceutical Main Business
Table 129. Xudong Haipu Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Heart Failure Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Heart Failure Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Heart Failure Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Heart Failure Treatment Sales Market Share by Country/Region (2024)
Figure 8. Heart Failure Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Heart Failure Treatment Market Size Market Share by Type in 2024
Figure 10. Heart Failure Treatment in Acute Heart Failure
Figure 11. Global Heart Failure Treatment Market: Acute Heart Failure (2020-2025) & ($ millions)
Figure 12. Heart Failure Treatment in Chronic Heart Failure
Figure 13. Global Heart Failure Treatment Market: Chronic Heart Failure (2020-2025) & ($ millions)
Figure 14. Global Heart Failure Treatment Market Size Market Share by Application in 2024
Figure 15. Global Heart Failure Treatment Revenue Market Share by Player in 2024
Figure 16. Global Heart Failure Treatment Market Size Market Share by Region (2020-2025)
Figure 17. Americas Heart Failure Treatment Market Size 2020-2025 ($ millions)
Figure 18. APAC Heart Failure Treatment Market Size 2020-2025 ($ millions)
Figure 19. Europe Heart Failure Treatment Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Heart Failure Treatment Market Size 2020-2025 ($ millions)
Figure 21. Americas Heart Failure Treatment Value Market Share by Country in 2024
Figure 22. United States Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Heart Failure Treatment Market Size Market Share by Region in 2024
Figure 27. APAC Heart Failure Treatment Market Size Market Share by Type (2020-2025)
Figure 28. APAC Heart Failure Treatment Market Size Market Share by Application (2020-2025)
Figure 29. China Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. India Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Heart Failure Treatment Market Size Market Share by Country in 2024
Figure 36. Europe Heart Failure Treatment Market Size Market Share by Type (2020-2025)
Figure 37. Europe Heart Failure Treatment Market Size Market Share by Application (2020-2025)
Figure 38. Germany Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 39. France Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Heart Failure Treatment Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Heart Failure Treatment Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Heart Failure Treatment Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Heart Failure Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 52. APAC Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 53. Europe Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 55. United States Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 56. Canada Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 57. Mexico Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 58. Brazil Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 59. China Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 60. Japan Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 61. Korea Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 63. India Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 64. Australia Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 65. Germany Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 66. France Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 67. UK Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 68. Italy Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 69. Russia Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 70. Egypt Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 71. South Africa Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 72. Israel Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 73. Turkey Heart Failure Treatment Market Size 2026-2031 ($ millions)
Figure 74. Global Heart Failure Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Heart Failure Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Heart Failure Treatment Market Size 2026-2031 ($ millions)